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A new microfluidic sample-preparation system is presented for the structural
investigation of proteins using small-angle X-ray scattering (SAXS) at
synchrotrons. The system includes hardware and software features for precise
fluidic control, sample mixing by diffusion, automated X-ray exposure control,
UVabsorbance measurements and automated data analysis. As little as 15 ml of
sample is required to perform a complete analysis cycle, including sample
mixing, SAXS measurement, continuous UV absorbance measurements, and
cleaning of the channels and X-ray cell with buffer. The complete analysis cycle
can be performed in less than 3 min. Bovine serum albumin was used as a model
protein to characterize the mixing efficiency and sample consumption of the
system. The N2 fragment of an adaptor protein (p120-RasGAP) was used to
demonstrate how the device can be used to survey the structural space of a
protein by screening a wide set of conditions using high-throughput techniques.
1. Introduction
The ability of small-angle X-ray scattering (SAXS) to provide
low-resolution structural information on proteins directly in
solution makes it the tool of choice for analysing the structural
changes of proteins in response to variations in their chemical
environment. However, in a traditional SAXS experiment
only part of the experimental space of the protein can be
investigated because of practical constraints. The experi-
mental conditions that may promote structural changes in a
given protein are often unknown prior to the experiment.
Thus, it is necessary to investigate the structural state of the
protein under a large number of experimental conditions. At
the same time, not only is the available quantity of many
macromolecules of biological interest limited, but the
frequency and duration of experimental campaigns at
synchrotron facilities are restricted. Furthermore, at most
synchrotron beamlines, sample changing tends to be time
consuming and, as a result, only a few experimental conditions
can be investigated within the allocated time. As a conse-
quence, when pre-defined samples have to be prepared and
transferred to the sample chamber manually prior to analysis,
only a fraction of the structural space of a given biomacro-
molecular system is investigated. Efficient sample changing, in
terms of both volume and time, is therefore of paramount
importance for exploring the rich structural space of many
biomacromolecular systems.
Key requirements to maximize the usefulness of structural
biology methods include the ability to operate in situ under
variable and close-to-native experimental environments, the
possibility of high-throughput studies, and the rapid genera-
tion of structural models (Svergun, 2010). The limitations of
current SAXS methods have prompted a significant interest in
developing robust high-throughput fully automated methods
for SAXS analysis which will fulfil these requirements. Recent
efforts have focused mainly on sample-changing robots
(Round et al., 2008; Hura et al., 2009; David & Pe´rez, 2009) in
order to automate experiments, minimize sample consump-
tion, save time and minimize human error. In terms of speed
and sample consumption, the most efficient method published
so far consists of using a pipetting robot to transfer 12 ml pre-
defined samples from a 96-well plate to a SAXS sample cell
(Hura et al., 2009). However, this approach lacks the signifi-
cant advantages offered by microfluidic devices. Firstly, with
microfluidic devices the sample conditions can easily be
changed ‘on the fly’ in response to changes in the observed
signal. Secondly, the inherent modular construction of
microfluidic devices offers the possibility of a synergistic
combination with complementary sample-handling or char-
acterization units.
Pollack et al. (1999, 2001) pioneered the combination of a
simple microfluidic diffusion-based mixer with SAXS
measurements in a flow-through cell to measure the folding
kinetics of proteins after a pH jump. Akiyama et al. (2002) and
Uzawa et al. (2004, 2006) have also developed a continuous-
flow mixing device to study the folding dynamics of several
proteins by SAXS. Panine et al. (2006) reviewed the status and
limitations of these continuous-flow microfluidic mixing
devices for SAXS. Marmiroli et al. (2009, 2010) used a free-jet
micromixer to study the kinetics of nanoparticle formation
using time-resolved SAXS. All these rapid-mixing devices
were designed specifically to study folding events or reaction
kinetics with submillisecond time resolution but did not offer
any flexibility in terms of experimental design. Otten et al.
(2005) have also used microfluidics to investigate soft matter
by SAXS. Microfluidic devices can also be used to perform
very specific functions. For example, Martel and co-workers
(Martel, Burghammer, Davies, Di Cola, Panine et al., 2008;
Martel, Burghammer, Davies, Di Cola, Vendrely & Riekel,
2008) have studied silk fibre assembly by SAXS in a concentric
flow microfluidic cell designed to mimic the geometry of the
spinning duct of the silkworm. Nevertheless, the search for
relevant structural states in proteins is not a straightforward
process and often requires the investigation of many different
sample conditions, a tedious procedure which calls for the
development of a very versatile high-throughput microfluidic
device. Toft et al. (2008) reported a high-throughput device for
protein structural analysis on a relatively simple microfluidic
front-end named the bioXTAS chip. This chip enabled auto-
mated mixing of samples by diffusion, and featured a 200 or
500 nl X-ray chamber. Protein consumption was limited to
36 ml, with a total cycle time, including protein and buffer
measurements, of 28 min. However, fluidic control was
compromised by the presence of fluidic compliance and the
absence of valves.
The new version of the bioXTAS chip presented here
features several additions, transforming the initial design from
a simple microfluidic front-end to a true ‘lab-on-a-chip’ device
including all the necessary steps of the analytical process, from
sample preparation to detection and semi-automated data
analysis. Protein dead-volume is minimized by the addition of
an on-chip sample reservoir, which allows the injection of
small sample aliquots using buffer or an immiscible fluid as the
carrying fluid. Motor-controlled rotary valves reduce the
impact of fluidic capacitance and allow accurate on-chip
sample preparation. Sample progress and protein concentra-
tion are continuously monitored by UV absorbance through
integrated optical fibres. Open-source software programs
developed in-house provide integrated synchronized control
of the beamline X-ray shutter systems and in situ automated
two-dimensional data reduction and preliminary analysis of
the isotropic SAXS data (Nielsen et al., 2009). The synergistic
combination of the microfluidics capabilities with the auto-
mation and data-processing software allows the user to make
on-the-fly adjustments to the experimental conditions based
on the observed data, providing SAXS beamline users with an
unprecedented flexibility and throughput for the analysis of
protein systems.
The function of many protein systems is connected with
structural flexibility and/or the formation of new inter- or
intramolecular protein contacts. For these protein systems, it is
of great relevance to develop high-throughput devices capable
of providing information on their three-dimensional
quaternary structures and thus gain insight into their struc-
ture–function relationship. In this paper, a GTPase-activating
protein (p120 RasGAP; Miao et al., 1996; Pamonsinlapatham
et al., 2009) was used as a model to demonstrate how the
bioXTAS chip can facilitate the exploration of the relevant
structural space of a protein. This protein, known as an
adaptor protein, possesses several conserved domains
mediating protein–protein interactions. Adaptor protein
systems are structurally interesting because they change their
shape and complex state when participating in cell-signalling
events (Flynn, 2001). In particular, p120 RasGAP plays a
central role in the inactivation of the proto-oncogenic protein
p21Ras, associated with various known cancer forms (Michod
et al., 2004; Pamonsinlapatham et al., 2008). The N-terminal
part of p120 RasGAP exists naturally in the cell as the N2
fragment (Yang & Widmann, 2001). This N2 fragment forms
protein complexes during cell signalling and is a relevant
therapeutic drug target (Ellis et al., 1990; Yang et al., 2005).
The exploration of the unknown structural space of the N2
fragment of p120 RasGAP is therefore potentially thera-
peutically relevant, because it is suggested that structural
changes mediate the relevant protein–protein contacts.
2. Methods
2.1. Microfluidic chip design and fabrication
2.1.1. Microfluidic device fabrication. The bioXTAS lab-
on-a-chip system consists of two modules, the mixing chip and
the sample-detection chip.
The mixing chip, illustrated in Fig. 1(a), supports the mixing
channels and rotor valves (marked A and B in Fig. 1). The
mixing chip and rotor valves consist of a 3 mm-thick poly-
(methyl methacrylate) (PMMA) substrate featuring 100 
200 mm micromilled channels. PMMA was used as the
substrate material because of its machinability. The fabrication
resulted in burr-free channels, and the sample chambers and
chips could be easily mass-produced. The channels are sealed
by bonding with a 1 mm-thick PMMA lid featuring micro-
drilled inlets and outlets. Bonding was achieved by exposing
the PMMA parts to UV light (30 mW cm2) for 2 min. The
exposed parts were then aligned and bonded thermally (10 kN
applied pressure for the mixing chip or 1 kN each for the
rotors, at 358 K for 1 h).
The sample-detection chip, illustrated in Fig. 1(b), consists
of a 1.7 mm-thick polystyrene (PS) substrate featuring 250 
400 mm micromilled channels. The detection area of the
sample chip, outlined in red in Fig. 1, consists of a cylindrical
X-ray cell (marked C in Fig. 1; 800 mm diameter, 1.7 mm deep)
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for SAXS analyses and a 2 mm-long UV cell (marked D in
Fig. 1). The channels and X-ray chamber are sealed on both
sides of the chip by a 125 mm-thick PS film bonded thermally
(3 kN applied pressure at 343 K for 1 h). The choice of PS as
the window material for the X-ray measurements was
supported by tests performed with a rotating-anode X-ray
source on Bruker Nanostar equipment (Toft et al., 2008). After
bonding, the optical fibres (200 mm core, FVP 200220240;
Polymicro Technologies, Phoenix, Arizona, USA) were
inserted through two micromilled grooves on either side of the
UV chamber (marked E in Fig. 1). The grooves were then
filled with an optical adhesive (NOA61; Norland Products
Inc., Cranbury, New Jersey, USA) by capillary action and
cured for 10 s under UV light (UV75; Thorlabs, Newton, New
Jersey, USA). The sample-detection chip inlet channel
(coloured purple in Fig. 1) is located on the front of the chip,
while the waste channel (the dashed purple line in Fig. 1) and
waste outlet (marked F in Fig. 1) are located on the back of the
chip.
Two alignment notches fitted with dowel pins allow the
quick assembly of the sample-detection and mixing chips.
Poly(dimethyl siloxane) (PDMS) O-rings, made in-house,
ensure a tight seal between the two clamped chips.
2.1.2. Rotor valves and protein reservoir. The three PMMA
rotational valves (marked A in Fig. 1) can be turned from the
on to the off position using stepper motors and position
encoders for correct positioning. Additionally, the rotational
valves can provide a connection from three different inlets to
the main channel for experiments requiring more fluidic
components. The larger rotational valve (marked B in Fig. 1)
features an on-chip protein reservoir in the form of a
meandering channel (turquoise). In order to reduce protein
dead-volume, small samples can be injected into the storage
channel of the valve and small aliquots can then be pushed
into the mixing chip using an immiscible fluid. Flow rates are
controlled by custom-built miniaturized and automated
syringe pumps. The combination of different component flow
rates is used to adjust the sample composition to the desired
specifications.
2.1.3. Automation software, hardware and beamline
control. The custom-developed control software ECON+
was developed in the Python programming language. ECON+
communicates with or directly controls all the hardware.
Unlike the automation setup used by Toft and co-workers,
which used commercial syringe pumps and lacked on-chip
valves (Toft et al., 2008), custom hardware was developed to
improve fluidic control. Syringe-pump stages were built in-
house and consisted of four stepper motors controlled by
sending pulses to a microstepping motor controller. The four
PMMA rotary valves were controlled by individual stepper
motors and four potentiometers allowed their accurate posi-
tioning.
Fig. 2 provides a schematic illustration of the automation
setup. Through a graphical user interface (GUI), the ECON+
software provides the user with the ability to control the
pumps and valves individually and to pre-program fully
automated series of measurements. A laptop running ECON+
controls the valve motors and the syringe-pump stage motors
through simple messages sent through a serial connection to
the control box.
X-ray exposures were initiated automatically through
ECON+. Network communication to the SPEC beamline
control server was achieved using the Python library devel-
oped by the European Synchrotron Radiation Facility
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Figure 1
Microfluidic chip design. The complete system consists of (a) a PMMA
mixing chip featuring valves and inlets, and (b) a PS sample-detection
chip where spectroscopic measurements are performed. Buffers and
reagents can be introduced through three separate inlets, each equipped
with a rotary valve (A). The rotary valves allow switching between four
states, connecting three different inlets with a mixing channel, and an
additional closed position. A larger rotary valve (B) doubles as an on-
chip protein reservoir. For protein dilution, the buffer channel (magenta
line) bifurcates around the protein inlet (blue) to laminate the protein
sample on two sides (purple). SAXS and UV absorbance measurements
can be performed simultaneously on the mixed sample in the detection
area of the chip (outlined in red). SAXS measurements are obtained
directly through the thin PS covers of the X-ray cell (C), while light is
guided to and from the UVabsorbance cell (D) by two integrated optical
fibres (E). The sample exits the chip through the waste channel (dashed
purple line) and outlet (F), both located on the back of the chip.
Figure 2
Schematic diagram of the automation setup.
(ESRF–Bliss Framework Project, 2006). ECON+ allows the
user to choose between three operational modes. Measure-
ments can be acquired at stopped-flow, in which the valves are
closed and pumps stopped after mixing of the sample,
continuous-flow, where the valves remain open and fresh
sample is continuously supplied during exposure and data
acquisition, or delayed exposure, in which the exposure is
initiated a certain time after mixing to allow equilibration.
More details on the automation software and schematics for
the electronic layout of the controller boards are given by
Nielsen (2010).
2.2. Sample preparation
2.2.1. Expression and purification of the N2 fragment.
Plasmid pASK-IBA13+ enclosing cDNA encoding (kindly
provided by Ole Kristensen, Department of Medicinal
Chemistry, University of Copenhagen, Denmark) was used for
the production of the p120 RasGAP N2 fragment with
attached strep tag (positions 176–444, SWISS-PROT database
No. P209336; Bairoch & Apweiler, 2000). Fresh protein
samples were prepared prior to the experiment and kept
refrigerated. The protein was expressed in Escherichia coli
BL21(DE3) pLysS cells. The harvested cells were suspended
in 100 mM Tris–HCl/150 mM NaCl/1 mM EDTA buffer. The
cell supernatant was loaded onto a strep-tag column and the
purification was conducted according to the standard protocol
(strep-tag purification protocol, IBA BioTAGnology,
Go¨ttingen, Germany). The strep tag was removed by over-
night incubation with thrombin. The N2 fragment protein was
dialysed into two different buffer solutions for a minimum of
48 h: non-reducing buffer, 10 mM Tris–HCl/100 mM NaCl
buffer pH 8, and reducing buffer, 10 mM Tris–HCl/100 mM
NaCl buffer/0.1 mM TCEP pH 8.
2.2.2. Sample preparation. Bovine serum albumin (BSA;
Sigma–Aldrich, St Louis, Missouri, USA) stock solutions were
prepared in 25 mM HEPES buffer. BSA stock concentrations
were 9 mg ml1. All protein samples were centrifuged for
20 min (9056g at 277 K) prior to SAXS data collection and
kept refrigerated. During measurements, protein and buffer
samples were kept in 5 ml glass syringes, mounted on pumps
connected to the bioXTAS chip. All protein concentrations
were determined using a Nanodrop 1000 spectrophotometer
(Thermo Fisher Scientific Inc, Wilmington, Delaware, USA)
prior to SAXS measurements.
2.3. Spectroscopic measurements
2.3.1. SAXS measurements. The SAXS measurements
presented here were obtained at the Swiss Light Source (SLS)
cSAXS beamline at the Paul Scherrer Institut (Villigen,
Switzerland). The SLS synchrotron is a third-generation light
source. Data were collected using a Pilatus 2M detector
(Henrich et al., 2009; Kraft et al., 2009), which is capable of
sustaining an 30 Hz full-frame readout rate. The operating
range of the cSAXS beamline is 6.2–18.6 keV, or 0.7–2 A˚.
SAXS data were acquired in the range 0.0085 < q < 0.61 A˚1,
where q = 4sin()/ is the scattering vector, 2 the scattering
angle and  the incident wavelength. An xy translation stage
was used to position the sample-detection chip in the X-ray
path. The exposure time was set to 4 s (5  0.8 s) and the spot
size on the sample was 200  400 mm (vertical  horizontal).
The beam was fully contained within the detection cell and did
not overlap with the PMMA cell walls.
2.3.2. SAXS data processing. A fully open-source software
program, bioXTAS RAW, developed in-house (Nielsen et al.,
2009), was used for the automated two-dimensional data
reduction and preliminary analysis of the isotropic SAXS data.
bioXTAS RAW handles all steps of the data reduction and has
the ability to normalize the sample data automatically and
subtract the buffer signals, and to obtain the pair distance
distribution function p(r) using the Bayesian indirect Fourier
transform algorithm (Hansen, 2000). The radius of gyration
Rg and the forward scattering intensity I(0) were obtained
through the Guinier approach (Guinier & Fournet, 1955). In
the N2 analyses, all scattering data were buffer-subtracted and
normalized with respect to protein concentration. I(0) was
used to estimate the molecular weight (MW) of N2 using BSA
as an MW standard. The programGNOM (Svergun, 1992) was
used for calculating the pair distance distribution functions of
the N2 data and estimation of the maximal distance (Dmax)
within the scatterer. The exposure time was set to 5  0.8 s
frames to assess possible radiation damage. Frames where
potential damage was observed could be discarded prior to the
averaging of individual frames. No radiation damage was
detected in the analysis of the N2 data.
2.3.3. UV measurements. Integrated optical fibres were
used to transmit the light from the UV source (DLS500;
Instrument Systems, Munich, Germany) to the diode array
spectrometer (USB 4000; Ocean Optics, Dunedin, Florida,
USA), shown as E in Fig. 1, in order to obtain continuous UV
absorbance measurements.
3. Results and discussion
3.1. bioXTAS lab-on-a-chip system
Through the development of custom-built hardware and
software controlling all aspects of a SAXS analysis, from
precise and accurate sample mixing to data acquisition and
processing, the bioXTAS chip developed by Toft et al. (2008)
has been transformed from a simple microfluidic front end to a
fully automated and integrated lab-on-a-chip device. The
microfluidic and spectroscopic components of the bioXTAS
lab-on-a-chip system are illustrated in Fig. 3. The lab-on-a-chip
is composed of two main sections: a mixing chip, where two to
four different components can be mixed by diffusion, and a
sample-detection chip, where spectroscopic (X-ray and UV)
measurements are performed simultaneously on the mixed
sample. UV data are acquired continuously and the comple-
mentary information they provide can be used to determine
sample concentration, to assess channel clean-up and sample
position, and to detect the presence of undesirable bubbles in
the system. Precise fluidic control was achieved using syringe
pumps built in-house, utilized in conjunction with on-chip
research papers
J. Appl. Cryst. (2011). 44, 1090–1099 Josiane P. Lafleur et al.  Automated microfluidic sample-preparation platform 1093
rotary valves. The volumetric flow rates achievable ranged
from 200 nl min1 when the system was equipped with 1 ml
glass syringes to 150 ml min1 when the system was equipped
with 5 ml glass syringes. The protein inlet channel is merged
with a split buffer channel, allowing lamination of the protein
sample from both sides to enhance mixing by diffusion. The
minimum distance from the point of mixing to the point of
detection is determined by the channel length required for
complete mixing by diffusion at the flow rates used. The
modular design allows for easy changing of the sample-
detection chip in case of radiation damage at high-brilliance
synchrotrons. Light is guided to and from the UV cell by two
integrated optical fibres, while X-ray measurements are
acquired directly through the thin polymeric film covering the
X-ray chamber, so they can both be performed simultaneously
without interference. A single device, i.e. mixing and sample-
detection chips combined, has been used for a period of 24 h
without signs of deterioration or leakage of the seals.
In a typical automated measurement, 15–30 ml samples were
mixed and transferred to the detection chambers. The protein
valve was then closed to allow cleaning of the chamber with
buffer, followed by a background measurement. The compo-
sition of the blank can be adjusted as easily and accurately as
that of the sample to ensure matrix-matched samples and
blanks. During cleaning, the SAXS and UV signals were
monitored to ensure proper cleaning. The whole procedure
could be completed within 3 min.
3.1.1. Reduction and data-analysis software. As new data
come in at high frequencies, especially at high-brilliance third-
generation synchrotrons, it is important to be able to analyse
the data fast enough for them to be useful in decision making,
as well as to identify potential problems, such as protein
aggregation, quickly. The bioXTAS RAW software (Nielsen et
al., 2009), developed to be used in conjunction with the
bioXTAS lab-on-a-chip, was used to read the raw two-
dimensional SAXS detector output files and plot the data
immediately as they were becoming available during the
measurement session. The software also allows rapid one-click
background subtraction. The instant feedback from the
automated reduction and the plotting of new incoming data, as
well as the ability to superimpose incoming plots and to
average multiple frames, provide an efficient way of quickly
analysing the data directly at the beamline.
3.2. Device characterization
3.2.1. Reproducibility and accuracy of the automated
mixing system. Toft et al. (2008) have already demonstrated
that high-quality SAXS data can be obtained using a nano-
litre-sized sample chamber. Here, we tested both the repro-
ducibility and the accuracy of the automated mixing system.
First, BSA dilution series were performed to assess the quality
of the SAXS data collected using the bioXTAS lab-on-a-chip
system. The composition of the sample entering the sample-
detection chip was varied by adjusting the flow rates of the
sample components at the various inlets on the sample-mixing
chip using the automated software. Fig. 4 shows that the
forward scattering intensity, I(0), is proportional to concen-
tration over the range studied (R2 = 0.98, 1–12% reproduci-
bility error at the 95% confidence level, N = 3). Data can be
acquired on a continuously renewed sample (during flow) or
on an immobilized sample (stopped flow) without any signif-
icant difference, as shown in Fig. 4. All subsequent data were
acquired on continuously renewed samples. The corre-
sponding scattering data and Guinier range are shown in
Supplementary Figs. S1 and S2,1 respectively.
Second, the accuracy of the automated mixing system was
assessed by comparing absorbance readings obtained for BSA
protein samples mixed on- and off-chip with HEPES buffer.
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Figure 3
Illustration of the bioXTAS lab-on-a-chip system. The bioXTAS platform
allows the continuous variation and monitoring (UV and SAXS) of
experimental solution conditions to promote and identify different
structural states in proteins in a high-throughput fashion.
Figure 4
SAXS data recorded for a BSA sample diluted gradually with HEPES
buffer (10 ml min1 combined flow rates, 15 ml total injected volume)
1 Supplementary figures discussed in this paper are available from the IUCr
electronic archives (Reference: EA5144). Services for accessing this material
are described at the back of the journal.
For the automated mixing (on-chip mixing), the total flow rate
(10 ml min1) was kept constant while the ratio of buffer flow
rate to protein flow rate was varied in order to achieve a range
of concentrations. Each concentration was injected for 180 s,
resulting in a total sample consumption of 30 ml. Hand-mixed
samples (off-chip mixing) were placed in disposable syringes
and manually injected into the sample-detection chip for
comparison. The results, presented in Table 1, show that there
is no significant difference in the UV intensities recorded
when the samples are manually mixed or when they are mixed
in a fully automated fashion on the chip. Hence, the bioXTAS
microfluidic system provides a precise and accurate means of
varying sample composition in a completely automated and
high-throughput fashion. Sample composition can be changed
on the fly in response to observed experimental results directly
from the control room, without the need for the user to access
the X-ray hutch where the microfluidic system and samples are
located.
3.2.2. Sample consumption. To determine the minimum
amount of sample required to replace completely the buffer in
the sample cell with a fresh sample, a protein sample was
continuously pumped into the microfluidic chip, initially filled
with buffer, at various flow rates while the forward scattering
was monitored continuously. The sample chamber is consid-
ered fully filled with the new sample when the forward scat-
tering becomes constant, resulting in a forward-scattering
intensity plateau. Fig. 5(a) shows the reference corrected raw
data and Fig. 5(b) the corresponding forward-scattering
intensity for BSA injected at 5 ml min1. As shown by the
dotted line in Fig. 5(b), a plateau is reached after the injection
of 15 ml of sample. After this point, although a slight positive
slope can be observed, the error bars for each replicate (N = 3,
95% confidence level) start overlapping, and doubling the
amount of sample injected does not result in a significant
increase in the forward-scattering intensity. Results obtained
at flow rates of 5, 10, 15 and 20 ml min1 show that the
forward-scattering intensity curves reach a plateau after the
injection of 15–25 ml of sample, with the highest sample
consumption associated with the highest flow rates. Complete
cleaning of the BSA-filled chamber required, on average, 22 ml
of buffer at a flow rate of 10 ml min1. Therefore, a complete
cycle consisting of sample introduction and mixing, X-ray
exposure, and cleaning of the channels and sample chamber
can be completed in less than 3 min at a flow rate of
15 ml min1. These results are comparable to those achieved
using current state-of-the-art sampler robots (Hura et al.,
2009). The marginal increase in sample consumption is greatly
compensated for by the automation of the sample-preparation
steps, the complementary UV measurements provided by the
modular setup and, last but not least, the added flexibility in
modifying the composition of a given sample during the course
of an experiment.
3.3. Screening of the structural space of the N2 fragment
The bioXTAS lab-on-a-chip can be used as a high-
throughput device to survey the structural space of a protein.
We studied the N2 fragment of p120 RasGAP as a model
protein to demonstrate the functionality and efficiency of the
bioXTAS system. This protein fragment interacts with parti-
cular proteins in the cell during cell-signalling events, and
structural changes and/or oligomerization are likely to influ-
ence protein function. The protein has been investigated
under different buffer conditions with and without varying
amounts of reducing agents, and, importantly, with varying
lengths of equilibration time. The variation in oligomeric state
under various conditions is illustrated in Figs. 6 and 7, where
the scattering plots [(a) and (d)] and p(r) plots [(b) and (e)]
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Table 1
Comparison of the absorbance measurements for BSA samples mixed
on- and off-chip.
Average absorbance at 280 nm (arbitrary units)
BSA concentration
(mg ml1) Mixed on-chip† Mixed off-chip‡
2.0 0.19 (1) 0.20 (1)
4.0 0.36 (1) 0.36 (1)
6.0 0.50 (2) 0.51 (1)
† Error reported at the 95% confidence level, N = 6. ‡ Error reported at the 95%
confidence level, N = 3.
Figure 5
Sample-consumption determination. BSA solution was continuously
injected into the microfluidic cell at a flow rate of 5 ml min1 for a total
injected volume of 33 ml. (a) Difference between the reference scattering
curve obtained after 33 ml of injected BSA and the scattering curves
obtained during injection. The SAXS intensities are shown as a function
of the reciprocal scattering vector q. (b) The forward-scatting intensity for
the scattering curves, I(0), estimated by the indirect Fourier transform
method.
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Figure 6
Exploration of the structural space of N2, starting from non-reduced conditions. The left-hand column shows data for N2 dilution with non-reducing
buffer: (a) background-subtracted SAXS data normalized to protein concentration, (b) the corresponding pair distance distribution functions, p(r), and
(c) estimated radius of gyration (Rg) and molecular weight (MW). The right-hand column shows data for N2 titration with the reducing agent TCEP (0–
10 mM): (d) background-subtracted SAXS data normalized to protein concentration, (e) the corresponding p(r) functions, ( f ) estimated Rg and MWas
a function of TCEP concentration, and (g) estimated Rg and MW for N2 diluted in 10 mM TCEP after 0–25 min equilibration. The raw data and p(r)
plots for the equilibrated solutions are shown in panels (d) and (e) using lighter blue colours.
illustrate the relative presence of larger or smaller distances as
well asDmax. Rg and MWare shown in Figs. 6(c), 6( f) and 6(g)
and 7(c) and 7( f).
Fig. 6 illustrates an exploration of the structural space of N2
fragments dialysed in a non-reducing buffer. As shown in
Figs. 6(a)–6(c), the scattering data, p(r) plots and Rg and MW
values display only minor changes as the protein concentra-
tion is varied. This indicates that the oligomeric state of N2 is
not significantly affected by variations in protein concentra-
tion. The protein solution at constant protein concentration
(4.1 mg ml1) was subsequently titrated with the reducing
agent TCEP. The N2 oligomer composition is only slightly
affected by the addition of TCEP, as shown in Figs. 6(d)–6( f).
However, a clear change in the oligomeric state of N2 is
observed after the sample has been allowed time to equilibrate
in 10 mM TCEP [pale-blue lines in Figs. 6(d), 6(e) and 6(g)]. In
Fig. 6(d) (pale-blue lines), the scattering curve changes shape,
and the falling intensity at lower q values is a clear signature of
smaller molecules in the solution. The decrease in area under
the p(r) curve shown in Fig. 6(e) (pale-blue lines) indicates
correspondingly that the average volume of the particles
decreases, although Dmax is unchanged. These experiments
show that equilibration in the presence of a reducing agent
influences the distribution of the oligomeric states of N2, but
also that the size of the highest-order oligomer present in any
of the analysed samples remains unchanged.
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Figure 7
Exploration of N2 protein pre-equilibrated in reducing buffer. The left-hand column shows data for N2 dilution with reducing buffer, 0.1 mM TCEP: (a)
background-subtracted SAXS data normalized to protein concentration, (b) the corresponding p(r) functions, and (c) estimated Rg and MW. The right-
hand column shows data for N2 (4.1 mg ml1) titrated with the reducing agent TCEP (0–10 mM): (d) background-subtracted SAXS data normalized to
protein concentration, (e) the corresponding p(r) functions, and ( f ) estimated Rg and MW as a function of TCEP concentration.
Fig. 7 illustrates an exploration of the structural space of N2
fragments dialysed in reducing buffer. A clear decrease in the
oligomeric state of N2 is observed as the protein concentration
is decreased by dilution with reducing buffer (Figs. 7a–7c),
illustrated by a falling intensity at lower q values. Changes in
the overall shape of the scattering curve are also observed. In
the p(r) plots (Fig. 7b), a decrease in Dmax indicates that the
larger oligomers disappear as the protein concentration is
lowered. This trend is also observed in the estimated Rg and
MW shown in Fig. 7(c). We conclude from these results that
oligomer formation is reversible, i.e. that an equilibrium
between larger and smaller oligomeric proteins exists in
solution. Furthermore, Figs. 7(d)–7( f) show that, in contrast
with samples that were not equilibrated with reducing agent
prior to titration, increasing the TCEP concentration leads to
a gradual increase in the size of the protein complex.
These results demonstrate the very complex behaviour of
the N2 fragment in oligomer formation. If the protein is stored
without a reducing agent, it adapts to a structural state where
oligomer formation is independent of protein concentration.
The oligomeric state is thus not in equilibrium, or at least the
equilibrium is strongly shifted towards the oligomeric state.
Even when large amounts of reducing agent are added, the
oligomeric state changes only slowly towards a smaller
protomer. Apparently, including small amounts of reducing
agent during storage of the protein causes the protein to adopt
a structural state that is in equilibrium between smaller and
larger oligomers. At lower concentrations, the oligomer is
significantly smaller than in the absence of any reducing agent,
while the formation of oligomers at higher protein concen-
trations supersedes the non-reduced oligomeric state. In such
conditions, the oligomeric state is sensitive to the concentra-
tion of the reducing agent. It can be concluded that the basic
structural state of individual protomers in the oligomers must
be different after long-term equilibration with and without
reducing agents.
The p120 RasGAP homo-interacting adaptor protein was
used in this work to demonstrate the capabilities of the
bioXTAS microfluidic setup. The reversible nature of the
oligomerization suggests that it could be part of a regulation of
p120 RasGAP-mediated cell signalling. Aside from the actual
biological function of the protein, the analysis clearly
demonstrates that protein structure and/or protein oligomeric
state are sensitive to the experimental conditions. This high-
lights the importance of performing buffer and concentration
screens on proteins where oligomerization and structural
changes may be of biological relevance. The bioXTAS setup
proved to be an ideal platform for this task. These experiments
illustrate how rapidly and easily structural changes and
oligomerization can be detected by synergistically combining
microfluidic sample handling with automated data analysis.
An important characteristic of the bioXTAS sample-
preparation platform is its ability to mix several components at
once thanks to the many inlets available. This feature offers
the possibility of mixing the desired buffers in situ, as shown in
the experiments above, extending the capability of the system
well beyond simple titration. These experiments also highlight
the importance of equilibration time. The versatility of the
bioXTAS microfluidic system not only facilitates exact moni-
toring of the equilibration time but also allows immediate
X-ray exposure upon establishment of the desired experi-
mental conditions.
4. Conclusions
The flexibility inherent in microfluidic devices, as well as the
high level of automation achievable and the greatly reduced
sample consumption, can provide an invaluable tool for users
at SAXS beamlines. This new lab-on-a-chip system provides
the ability to perform many experiments on samples as small
as 15 ml in a fully automated fashion. This is especially valu-
able in the context of third-generation synchrotrons, where
exposure times are fast and high-throughput microfluidic
devices can help maximize the use of the limited beamtime
available. The performance of the system is comparable, and
in some cases superior, to current methods. The modular
design simplifies the integration of various complementary
analysis units, such as the UV absorbance measurements
demonstrated here. The system was used successfully to screen
for changes in the oligomeric state of the N2 protein as a
function of concentration, equilibration time and presence of a
reducing agent, thereby elucidating the relevant structural
states of the protein system. These results demonstrate the
efficiency of the system and its ability to identify experimental
conditions that will lead to structural changes in biologically
relevant macromolecules.
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